Efficacy of tenofovir in covid-19

Phase 3

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20200421047155N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Patients with COVID-19 pulmonary infection
Established diagnosis of COVID-19 with RTPCR
Patients older than 18 years

Exclusion Criteria

Reinfection with COVID-19
Pregnancy
Patients with immunodeficiency
Individuals who are reluctant to participate in study
Prior history of allergy to used drugs
Documented history of any other medical condition for which the patient require to use a certain medication routinely.
Creatinin clearance less than 30 mg/min
Oxygen Saturation (SpO2) less than 40%
ICU patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vital signs. Timepoint: daily. Method of measurement: direct physical examination.;Body temperature. Timepoint: daily. Method of measurement: thermometer.;White blood cell count. Timepoint: daily. Method of measurement: blood sample analysis.